Non-alcoholic fatty liver disease (NAFLD)
Non-alcoholic fatty liver disease caused by type IX glycogenosis - a series of cases in children
24
Hypoadiponectinemia as a marker of increased cardiovascular risk in patients with non-alcoholic fatty liver disease: correlation with albumin/creatinine ratio
5
Effects of tin caulis dendrobium polysaccharide on the prevention of non-alcoholic fatty liver disease in rats
5
Açai improves non-alcoholic fatty liver disease (NAFLD) induced by fructose.
8
Non-alcoholic fatty liver disease: risk factors and relationship with the metabolic syndrome
30
A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.
19
Editor’s Pick: Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?
7
DISTINCT PHENOTYPE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH LOW LEVELS OF FREE COPPER AND OF CERULOPLASMIN
5
Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.
16
Lifestyle Modification through Dietary Intervention: Health Promotion of Patients with Non-Alcoholic Fatty Liver Disease
8
Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals
5
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
5
Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease
7
Metabolic pathway of non-alcoholic fatty liver disease: Network properties and robustness
12
EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS
5
NON-ALCOHOLIC FATTY LIVER DISEASE AT OUR INSTITUTE
5
Apoptosis and miRNAs in non-alcoholic fatty liver disease pathogenesis
217
The Effect of Chlorella vulgaris Supplementation on Liver Enzymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease
9
Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.
17
The efficacy of saxagliptin in T2DM patients with non-alcoholic fatty liver disease: preliminary data
5